Abdominal Aorta Aneurysm Clinical Trial
Official title:
Multicenter Clinical Study Assessing the Performance and the Safety of the Second Generation Antimicrobial Graft in Abdominal Position
Safety and performance of an anti-microbial vascular graft in the treatment of aneurysmal and occlusive disease of the abdominal aorta.
The purpose of this multi center, single arm study is to demonstrate the safety and
performance of the Second Generation Anti-Microbial (InterGard Synergy) vascular graft in
the treatment of aneurismal and occlusive diseases of the abdominal aorta.
The primary endpoint is the assessment of primary and secondary graft patency. The secondary
endpoints were the assessment of adverse events and the assessment of triclosan and silver
contents in the serum over the time.
;
Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03974958 -
Circulating microRNAs and Degenerative Abdominal Aorta Aneurysm
|
N/A | |
| Completed |
NCT04691726 -
Impact of Intra- and Postoperative Continuous Infusion of Lidocaine on Analgesia in Vascular Anaesthesia
|
Phase 4 |